Culley Brian M
SEC insider (Form 3/4/5 filer). CIK 0001310683. President and CEO at Lineage Cell Therapeutics, Inc. (LCTX). 10 reported Form 4/5 transactions since Sep 2024; latest on Mar 12, 2026. Located in CARLSBAD, CA.
Companies Culley Brian M has filed insider reports for
- Lineage Cell Therapeutics, Inc. (LCTX): Director, Officer, President and CEO
Culley Brian M
CIK: 0001310683
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Lineage Cell Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Mar 12, 2026LCTX
Lineage Cell Therapeutics, Inc.
PurchaseDirect15K shares at avg. $1.63$24K - Mar 5, 2026LCTX
Lineage Cell Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
3.3M shares- - Feb 11, 2026LCTX
Lineage Cell Therapeutics, Inc.
Tax PaymentDirect12.9K shares at avg. $1.80$23K - Feb 11, 2026LCTX
Lineage Cell Therapeutics, Inc.
ExerciseDirect31.3K shares- - Dec 19, 2025LCTX
Lineage Cell Therapeutics, Inc.
Tax PaymentDirect334 shares at avg. $1.68$561.12 - Dec 19, 2025LCTX
Lineage Cell Therapeutics, Inc.
AwardDirect8.9K shares- - Mar 10, 2025LCTX
Lineage Cell Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
2.3M shares- - Feb 11, 2025LCTX
Lineage Cell Therapeutics, Inc.
ExerciseDirect31.2K shares- - Feb 11, 2025LCTX
Lineage Cell Therapeutics, Inc.
Tax PaymentDirect12.5K shares at avg. $0.65$8K - Nov 21, 2024LCTX
Lineage Cell Therapeutics, Inc.
PurchaseDirect40K shares at avg. $0.60$24K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 12, 2026 | LCTX Lineage Cell Therapeutics, Inc. | Purchase | 15,000 | $1.63 | $24,375 | Direct |
| Mar 5, 2026 | LCTX Lineage Cell Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 3,250,000 | - | - | Direct |
| Feb 11, 2026 | LCTX Lineage Cell Therapeutics, Inc. | Tax Payment | 12,869 | $1.80 | $23,164 | Direct |
| Feb 11, 2026 | LCTX Lineage Cell Therapeutics, Inc. | Exercise | 31,250 | - | $0 | Direct |
| Dec 19, 2025 | LCTX Lineage Cell Therapeutics, Inc. | Tax Payment | 334 | $1.68 | $561 | Direct |
| Dec 19, 2025 | LCTX Lineage Cell Therapeutics, Inc. | Award | 8,925 | - | - | Direct |
| Mar 10, 2025 | LCTX Lineage Cell Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 2,300,000 | - | - | Direct |
| Feb 11, 2025 | LCTX Lineage Cell Therapeutics, Inc. | Exercise | 31,249 | - | - | Direct |
| Feb 11, 2025 | LCTX Lineage Cell Therapeutics, Inc. | Tax Payment | 12,547 | $0.65 | $8,156 | Direct |
| Nov 21, 2024 | LCTX Lineage Cell Therapeutics, Inc. | Purchase | 40,000 | $0.60 | $24,000 | Direct |
1-10 of 10 transactions